Under the U.S. DSCSA, pharmaceutical and healthcare companies are required to electronically exchange item-level product traceability information. This creates new logistical challenges for drop shipments, 340B, and returns, leaving many in the industry asking questions like:
- How do manufacturers drop shipping product to dispensers send serialized T2 data electronically if they don't have a direct commercial relationship?
- Who should provide contract pharmacies with the data needed for receiving 340B product—the covered entity or the distributor?
- How does the wholesale distributor verify returned product, particularly if they didn’t originally purchase it directly from the manufacturer?
These scenarios must be addressed to ensure DSCSA compliance by the end of the stabilization period in November. Download this infographic and see how the TraceLink supply chain network platform can help address the core challenges underpinning these scenarios.
TraceLink’s network platform, with Integrate Once, Interoperate with Everyone™ capability, revolutionizes compliance and operational efficiency for dispensing customers. By seamlessly connecting with an expansive digital network of supply chain partners, TraceLink ensures robust compliance with the Drug Supply Chain Security Act (DSCSA), swiftly manages compliance exceptions, and enables streamlined digital recalls. Furthermore, its advanced analytics capabilities facilitate the prediction of drug shortages, enhancing supply chain resilience. This integration offers pharmacies, hospitals, and other dispensers a comprehensive solution that not only meets regulatory demands but also optimizes inventory management and maintains the integrity of the drug supply, ensuring patient safety and continuity of care.
